High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

about

The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis The Impact of General Medical Conditions in Obsessive-Compulsive Disorder.

P2860

Q41185364-BBEE7273-7DD9-46CD-ADC9-081A2EE1E1C8 Q55001474-E3578874-EF66-47FA-9ED7-56B60A7752DB

P2860

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

Item

http://www.wikidata.org/entity/Q41313523

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

@en

type

Item

label

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

@en

prefLabel

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

@en

P1476

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder

@en

P2093

Francesco Barone-Adesi

http://www.w3.org/2001/XMLSchema#string

Giuseppe Maina

http://www.w3.org/2001/XMLSchema#string

Umberto Albert

http://www.w3.org/2001/XMLSchema#string

Virginia D'Ambrosio

http://www.w3.org/2001/XMLSchema#string

P2860

A modified poisson regression approach to prospective studies with binary data

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done?

Access to medical care among persons with psychotic and major affective disorders.

Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population

Associations between anxiety, depression, antidepressant medication, obesity and weight gain among Canadian women

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.

P2888

s00213-015-4085-9

P304

49-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-015-4085-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Virginio Salvi

P577

2015-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026921095

http://www.w3.org/2001/XMLSchema#string

P698

26407602

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

metabolic syndrome

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

about

P2860

P2860

High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921